Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus antigen-positive tumor cell
- Molecular classification
- Tumor cell, Virus-infected cell, Antigen-presenting cell (indirectly)
01
Overview
A hepatitis B virus antigen-positive tumor cell is a malignant cell, typically found in the liver (HCC or ICC), that expresses hepatitis B virus antigens, particularly HBsAg, on its surface or within its cytoplasm. These cells are associated with chronic HBV infection and HBV-related cancers. They contribute to oncogenesis and immune evasion and can be targeted by immunotherapies like engineered TCR-T cells.
- Other names
- HBsAg-positive tumor cellHBV antigen expressing tumor cellHBV-related tumor cell
02
Mechanism of action
Tumor cell killing via engineered T-cells targeting HBV-derived peptides (e.g., S20); Viral suppression (Entecavir, Tenofovir)
03
Biological functions
Antigen presentationImmune evasionCell proliferation (cancer)Oncogenesis
04
Disease associations
Hepatocellular carcinoma (HCC)Intrahepatic cholangiocarcinoma (ICC)Chronic Hepatitis B infectionHBV-related malignancyDiffuse large B-cell lymphoma (in some cases)
05
Safety considerations
Immune-related adverse events (TCR-T therapy)Risk of viral reactivation
06
Interacting drugs
SCG101 (TCR-T therapy)
2 more in the full profile.
07
Biomarkers
HBsAg expression (tumor tissue)HLA-A2 positivity (for S20-targeted therapies)
Beyond the preview
Go deeper on Hepatitis B virus antigen-positive tumor cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B virus antigen-positive tumor cell.